Cognition Therapeutics, Inc. Interest Income (Expense), Nonoperating, Net
Cognition Therapeutics, Inc. (CGTX) reported Interest Income (Expense), Nonoperating, Net of -$3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-07
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$3.00K.
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was -$5.00K.
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was -$5.00K.
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $0.00.
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2025 was -$13.00K.
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2024 was -$25.00K.
- Cognition Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2023 was -$27.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.00K 10-Q · filed 2026-08-07 | -$8.00K 10-Q · filed 2026-08-07 | -$13.00K derived: sum of 3 quarters · filed 2026-08-07 | -$13.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-08 | -$10.00K derived: sum of 2 quarters · filed 2026-05-08 | -$10.00K derived: sum of 3 quarters · filed 2026-05-08 | -$13.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$5.00K derived: sum of 2 quarters · filed 2026-03-26 | -$8.00K derived: sum of 3 quarters · filed 2026-08-07 | -$13.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.00K derived: sum of 2 quarters · filed 2026-08-07 | -$8.00K 10-Q · filed 2025-11-06 | -$13.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$3.00K 10-Q · filed 2026-08-07 | -$8.00K 10-Q · filed 2026-08-07 | -$13.00K derived: sum of 3 quarters · filed 2026-08-07 | -$16.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-08 | -$10.00K derived: sum of 2 quarters · filed 2026-05-08 | -$13.00K derived: sum of 3 quarters · filed 2026-05-08 | -$20.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$8.00K derived: sum of 2 quarters · filed 2026-03-26 | -$15.00K derived: sum of 3 quarters · filed 2026-03-26 | -$25.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | -$3.00K 10-Q · filed 2025-11-06 | -$10.00K derived: sum of 2 quarters · filed 2025-11-06 | -$20.00K 10-Q · filed 2025-11-06 | -$29.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$7.00K 10-Q · filed 2025-08-07 | -$17.00K 10-Q · filed 2025-08-07 | -$26.00K derived: sum of 3 quarters · filed 2025-08-07 | -$28.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$10.00K 10-Q · filed 2025-05-07 | -$19.00K derived: sum of 2 quarters · filed 2025-05-07 | -$21.00K derived: sum of 3 quarters · filed 2025-05-07 | -$27.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$11.00K derived: sum of 2 quarters · filed 2025-03-20 | -$17.00K derived: sum of 3 quarters · filed 2025-03-20 | -$27.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$2.00K 10-Q · filed 2024-11-13 | -$8.00K derived: sum of 2 quarters · filed 2024-11-13 | -$18.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$6.00K 10-Q · filed 2024-08-08 | -$16.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |